Cambridge-based digital health platform Healthera has raised £3 million Series A, in a round led by ADV with participation from Cambridge Enterprise. Healthera connects patients to a network of hundreds of pharmacies and NHS GPs, allowing them to order and track their prescriptions, access clinical services, and monitor their medication intake in one digital end-to-end solution.
Nearly half of all adults take long-term medication to treat their conditions, amounting to over 1 billion prescription items per year in the UK alone. Currently most patients still rely on manual methods to obtain prescriptions from their healthcare providers, often requiring paperwork and multiple physical visits.
Healthera's vision is to build the first smart platform to digitise medicine for 98% of patients, local community pharmacies and GPs.
“Over the past months, Healthera’s platform has won the confidence of the market as shown by the speed of adoption among patients, healthcare professionals, and NHS organizations," said Quintus Liu, CEO at Healthera.
“Repeat medical prescriptions are used by millions in the UK each year and many more across the world," said Mike Dimelow, Chief Investment Officer at ADV. "Paperwork, physical appointments and lack of focus on patient’s needs make this an all too often inefficient process for all involved. Healthera is tackling this by bringing clinical services, prescription and medicine intake monitoring in one consumer platform which has seen rapid uptake from pharmacists and patients since launching in Q4 2017. We expect to see this user base grow even more rapidly as the team expands across the UK and beyond towards a time of effortless prescription for those in need.”